Aslı Korur

Aslı Korur

Auto-generated profile, based on publicly available information

Aslı Korur

Department of Family Medicine, Baskent University Faculty of Medicine

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2016 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
PKPelin Kardaş Karacaoglu
Pelin Kardaş Karacaoglu
SASuheyl Asma
Suheyl Asma
AKAslı Korur
Aslı Korur
SSSoner Solmaz
Soner Solmaz
NBNurhilal Turgut Buyukkurt
Nurhilal Turgut Buyukkurt
HÖHAKAN ÖZDOĞU
HAKAN ÖZDOĞU

30 September 2019 in Eurasian Journal of Family Medicine
Verified
Journal Article
Closed access
AKAslı Korur
Aslı Korur
DADidar Yanardag Acik
Didar Yanardag Acik
SSSoner Solmaz
Soner Solmaz
CGCigdem Gereklioglu
Cigdem Gereklioglu
SASuheyl Asma
Suheyl Asma
HÖHAKAN ÖZDOĞU
HAKAN ÖZDOĞU
Aim: Anemia is a public health problem worldwide. Cost effectiveness and efficient use of resources are vitally important. Red blood cell distribution width, which can be obtained from a standard complete blood count, is a measure of the variability in size of circulating erythrocytes. The present study was performed to investigate whether red blood cell distribution width can be used to predict response to iron therapy. Methods: This study was conducted in 50 patients admitted to hematology and family medicine clinics. Complete blood count and reticulocyte count were determined on day 5; complete blood count was examined 1 month after commencement of therapy. Results: Statistically significant differences were detected between hemoglobin levels and red blood cell distribution width values at the time of diagnosis and on day 5 and after 1 month of therapy. A significant positive correlation was found between the increase in red blood cell distribution width and the increase in hemoglobin. Conclusion: Red blood cell distribution width may be used in place of reticulocyte count to predict response to iron therapy. Red blood cell distribution width is the best biomarker for this purpose as a component of complete blood count, and therefore it may be accepted as superior to reticulocyte count.